Improved methodical approach for quantitative BRET analysis of G protein coupled receptor dimerization

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Szalai, Bence ^a,b   Hoffmann, Péter ^a   Prokop, Susanne ^a   Erdélyi, László ^a,b   Várnai, Péter ^a,b   Hunyady, László ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM SENSING RECEPTOR; CANNABINOID 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; RAPAMYCIN; VASOPRESSIN V2 RECEPTOR; ARGININE VASOPRESSIN RECEPTOR 2, HUMAN; PROTEIN BINDING; VASOPRESSIN RECEPTOR;

ANALYTIC METHOD; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONTROLLED STUDY; DIMERIZATION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONTE CARLO METHOD; PLASMID; PROTEIN EXPRESSION; CHEMISTRY; METABOLISM; PROCEDURES; PROTEIN MULTIMERIZATION; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; DATA INTERPRETATION, STATISTICAL; HEK293 CELLS; HUMANS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECEPTORS, VASOPRESSIN;

EID: 84908131504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109503     Document Type: Article

References (38)

1. Ferre S, Franco R (2010) Oligomerization of G-protein-coupled receptors: a reality. Curr Opin Pharmacol 10(1): 1-5.
2. Milligan G (2013) The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization. Mol Pharmacol 84(1): 158-169.
3. Smith NJ, Milligan G (2010) Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62(4): 701-725.
4. Szidonya L, Cserzo M, Hunyady L (2008) Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J Endocrinol 196(3): 435-453.
5. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, et al. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396(6712): 683-687.
6. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, et al. (2010) Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 6(8): 587-594.
7. Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, et al. (2010) Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci U S A 107(5): 2319-2324.
8. Ferre S, Baler R, Bouvier M, Caron MG, Devi LA, et al. (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5(3): 131-134.
9. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, et al. (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 102(25): 9050-9055.
10. Dorsch S, Klotz KN, Engelhardt S, Lohse MJ, Bunemann M (2009) Analysis of receptor oligomerization by FRAP microscopy. Nat Methods 6(3): 225-230.
11. Calebiro D, Rieken F, Wagner J, Sungkaworn T, Zabel U, et al. (2013) Single-molecule analysis of fluorescently labeled G-protein-coupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci U S A 110(2): 743-748.
12. Marullo S, Bouvier M (2007) Resonance energy transfer approaches in molecular pharmacology and beyond. Trends Pharmacol Sci 28(8): 362-365.
13. Mercier JF, Salahpour A, Angers S, Breit A, Bouvier M (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277(47): 44925-44931.
14. Szalai B, Barkai L, Turu G, Szidonya L, Varnai P, et al. (2012) Allosteric interactions within the AT(1) angiotensin receptor homodimer: role of the conserved DRY motif. Biochem Pharmacol 84(4): 477-485.
15. Drinovec L, Kubale V, Nohr Larsen J, Vrecl M (2012) Mathematical models for quantitative assessment of bioluminescence resonance energy transfer: application to seven transmembrane receptors oligomerization. Front Endocrinol (Lausanne) 3: 104.
16. James JR, Oliveira MI, Carmo AM, Iaboni A, Davis SJ (2006) A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 3(12): 1001-1006.
17. Kufareva I, Stephens B, Gilliland CT, Wu B, Fenalti G, et al. (2013) A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer. Methods Mol Biol 1013: 93-127.
18. Woo J, von Arnim AG (2008) Mutational optimization of the coelenterazine-dependent luciferase from Renilla. Plant Methods 4: 23.
19. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, et al. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20(1): 87-90.
20. Zacharias DA, Violin JD, Newton AC, Tsien RY (2002) Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296(5569): 913-916.
21. Toke J, Czirjak G, Patocs A, Enyedi B, Gergics P, et al. (2007) Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clin Endocrinol (Oxf) 67(3): 385-392.
22. Varnai P, Toth B, Toth DJ, Hunyady L, Balla T (2007) Visualization and manipulation of plasma membrane-endoplasmic reticulum contact sites indicates the presence of additional molecular components within the STIM1-Orai1 Complex. J Biol Chem 282(40): 29678-29690.
23. Balla A, Toth DJ, Soltesz-Katona E, Szakadati G, Erdelyi LS, et al. (2012) Mapping of the localization of type 1 angiotensin receptor in membrane microdomains using bioluminescence resonance energy transfer-based sensors. J Biol Chem 287(12): 9090-9099.
24. Gyombolai P, Boros E, Hunyady L, Turu G (2013) Differential beta-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor. Mol Cell Endocrinol 372(1-2): 116-127.
25. Turu G, Szidonya L, Gaborik Z, Buday L, Spat A, et al. (2006) Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors. FEBS Lett 580(1): 41-45.
26. Fallahi-Sichani M, Linderman JJ (2009) Lipid raft-mediated regulation of Gprotein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One 4(8):e6604.
27. Woolf PJ, Linderman JJ (2003) Self organization of membrane proteins via dimerization. Biophys Chem 104(1): 217-227.
28. Varnai P, Thyagarajan B, Rohacs T, Balla T (2006) Rapidly inducible changes in phosphatidylinositol 4,5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J Cell Biol 175(3): 377-382.
29. Wilson PC, Lee MH, Appleton KM, El-Shewy HM, Morinelli TA, et al. (2013) The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem 288(26): 18872-18884.
30. Cottet M, Albizu L, Perkovska S, Jean-Alphonse F, Rahmeh R, et al. (2010) Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes. Curr Opin Pharmacol 10(1): 59-66.
31. Granier S, Terrillon S, Pascal R, Demene H, Bouvier M, et al. (2004) A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein. J Biol Chem 279(49): 50904-50914.
32. Loison S, Cottet M, Orcel H, Adihou H, Rahmeh R, et al. (2012) Selective fluorescent nonpeptidic antagonists for vasopressin V(2) GPCR: application to ligand screening and oligomerization assays. J Med Chem 55(20): 8588-8602.
33. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, et al. (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17(4): 677-691.
34. Jensen AA, Hansen JL, Sheikh SP, Brauner-Osborne H (2002) Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur - J Biochem 269(20): 5076-5087.
35. Jiang Y, Minet E, Zhang Z, Silver PA, Bai M (2004) Modulation of interprotomer relationships is important for activation of dimeric calcium-sensing receptor. J Biol Chem 279(14): 14147-14156.
36. Khan MA, Conigrave AD (2010) Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling. Br J Pharmacol 159(5): 1039-1050.
37. Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, et al. (2006) Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum Mol Genet 15(14): 2200-2209.
38. Ray K, Hauschild BC, Steinbach PJ, Goldsmith PK, Hauache O, et al. (1999) Identification of the cysteine residues in the amino-terminal extracellular domain of the human Ca(2+) receptor critical for dimerization. Implications for function of monomeric Ca(2+) receptor. J Biol Chem 274(39): 27642-27650.